H1, a clinical trial intelligence platform provider, has launched GenosAI, an AI tool embedded into its platform, Trial Landscape. The platform helps to analyze complex inquiries related to clinical trials.
GenosAI offers insights into competing trials, streamlines site selection, promotes diversity in clinical trials, assists with site selection and feasibility assessments, improves trial design, and breaks down data barriers.
H1 is a provider of several platforms to assist with carrying out clinical trials. The company has four platforms that help with providing insights into different aspects of clinical trials, including key opinion leader identification and engagement, performance, site selection and diversity, data management, and claims-based settlements. The company claims that its Trial Landscape platform generates insights based on the results of 490,000 trials, 25 million publications, 10 million healthcare providers, 240 million patients, and 11 billion global claims.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.